Search - tctmd.com

Displaying 321 - 340 of 389

Sort: Relevancy | Date

News Daily News

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

L.A. McKeown

July 03, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Yael L. Maxwell

June 27, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Yael L. Maxwell

April 17, 2014

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

初期研究显示利伐沙班拮抗剂安全、有效

December 30, 2013

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

Presentation

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

Presenter: Mark Crowther

December 22, 2013

Presentation TCT 2013

Anticoagulation For Prosthetic Valves: Warfarin for Mechanical Valves

Presenter: Bernard Gersh

October 31, 2013

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

L.A. McKeown

September 20, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

Advertisement

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

初期研究显示利伐沙班拮抗剂安全、有效

Rivaroxaban Antidote Appears Safe, Effective in Early Study

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

Anticoagulation For Prosthetic Valves: Warfarin for Mechanical Valves

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content